You are here

Home / Resources / Key Material
Export 19 results:
Filters: First Letter Of Last Name is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Tacket, C. O., Sztein M. B., Losonsky G., Abe A., Finlay B. B., McNamara B. P., et al. (2000).  Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68, 6.
Tamrakar, S. B., Haluska A., Haas C. N., & Bartrand T. A. (2011).  Dose-Response Model of Coxiella burnetii (Q Fever). Risk Analysis. 31, 120–128.
Tamrakar, S. B., Haluska A., Haas C. N., & Bartrand B. A. (2011).  Dose-Response Model of Coxiella burnetii (Q Fever). Risk Analysis. 31, 120-128.
Tansey, J., & O'riordan T. (1999).  Cultural theory and risk: a review. Health, risk & society. 1, 71-90.
Tärnvik, A.., & Berglund L.. (2003).  Tularaemia. European Respiratory Journal. 21, 2.
Taylor, D. M., Woodgate S. L., & Atkinson M. J. (1995).  Inactivation of the bovine spongiform encephalopathy agent by rendering procedures. Veterinary Record. 137(24), 
Taylor-Robinson, D.., & Bynoe M.. L. (1963).  Para-influenza 2 virus infections in adult volunteers. The Journal of Hygiene. 61, 4.
Ternhag, A.., Asikainen T.., Giesecke J.., & Ekdahl K.. (2007).  A Meta-Analysis on the Effects of Antibiotic Treatment on Duration of Symptoms Caused by Infection with Campylobacter Species. Clinical Infectious Diseases. 44, 5.
Teunis, P.., Takumi K.., & Shinagawa K.. (2004).  Dose response for infection by Escherichia coli O157:H7 from outbreak data. Risk Analysis: An Official Publication of the Society for Risk Analysis. 24, 401-407.
Teunis, P. F. M., Nagelkerke N. J. D., & Haas C. N. (1999).  Dose response models for infectious gastroenteritis. Risk Analysis. 19, 1251–1260.
Teunis, PFM., Medema GJ., Kruidenier L., & Havelaar AH. (1997).  Assessment of the risk of infection by Cryptosporidium or Giardia in drinking water from a surface water source. Water Research. 31, 1333–1346.
Thomas, V., McDonnell G., Denyer S. P., & Maillard J-Y. (2010).  Free-living amoebae and their intracellular pathogenic microorganisms: risks for water quality. FEMS microbiology reviews. 34, 231–259.
Titball, R. W., & Sjostedt A. (2003).  Francisella tularensis: an overview. American Society for Microbiology News. 69, 558-563.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical infectious diseases. 49, 1512–1519.
Tribble, D. R., Baqar S., Scott D. A., Oplinger M. L., Trespalacios F., Rollins D., et al. (2010).  Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78, 4.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 49, 1512-1519.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
M. Trivendi, P. M. (2011).  Severe Acute Respiratory Syndrome (SARS). 12, 1-31.
Tunney, C. (2017).  Newspaper Coverage of the Flint Water Crisis: An Empirical Analysis to Support a New Model for Latent Environmental Disasters.